The proliferation status estimated from the expression of Ki-67 was associated with advanced stages and prognosis of MM (42), which is why the assessment of MM has been challenged using 11C-4DST rather than 11C-MET and 18F-FDG PET/CT. The gene discussed is MKI67; the disease is Miyoshi myopathy.